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Abstract
The search to understand how the HIV virus spreads inside the human body and how
the immune response works to control it has motivated studies related to Mathematical
Immunology. Actually, researches include the idea of mathematical models represent-
ing the dynamics of healthy and infected cell populations and focusing on mechanisms
used by HIV to invade target-host cells, viral dissemination (which leads to depletion
of the T-cell pool and collapse of the immune system), and impairment of immune re-
sponse. In this work, we show the importance of specific cells of immune response,
as infection vectors involved in the dynamics of viral proliferation within an untreated
patient, by using an ordinary differential equation model in which we considered that
the virus infected target-cells such as macrophages, dendritic cells, and lymphocytes
TCD4 and TCD8 populations. In conclusion, we demonstrate the importance of each
cell-host and the threshold of viral establishment and posterior spread based on the
presence of infected macrophages and dendritic cells in antigen-presenting processing,
which leads to new infections (by wild or mutant virions) after immune response acti-
vation episodes. We presented an R0 expression that provides the major parameters of
HIV infection. Additionally, we suggest some possibilities of new targets for functional
vaccines.
Keywords: Mathematical Modeling; HIV/AIDS; Immune System; Viral Infection;
Pre-Exposure Prophylaxis; Basic Reproduction Number; Vaccine
1. Introduction
The epidemiology of infectious diseases has been studied for years and has been
considered the control (and eradication) of infection dependent on the dynamics of epi-
demic process dynamics and human immunity [1–3]. The levels of immunization de-
pend on vaccination use, the probability of occurrence of new cases and the metabolic
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consequences of an infected host. They are developed according to the level of com-
plexity, the objective to be reached, the host-pathogen relationship and the population.
Based on the HIV infection process and dissemination, the range of maximum effi-
ciency of a particular vaccine may not be reached [4, 5] because of the number of
resistant strains that appear after treatment with antiretroviral drugs [6, 7] or by the for-
mation of cellular reservoirs (macrophages and lymphocytes TCD4 cells chronically
infected) [8, 9]. Because viral secondary infections can occur in antigen presentation
and lymphocyte activation or by macrophage activation in inflammation sites, a math-
ematical index expression considering these factors could help the effort to control and
eradicate the disease more effectively.
A concept of great interest in epidemiology is the Basic Reproduction Number, R0,
which is the expected number of secondary cases per primary cases of infection in a
completely susceptible population. This concept was initially proposed by MacDon-
ald in the 1950s [10], when it was shown that for cases in which R0 >1, the disease
spreads into the population, and if R0 < 1, the disease will not progress. However,
in a complex system, the deduction of simple expressions of R0 is complicated due to
the persistence of infection phenomena, such as various conditions and characteristics,
the complexity level, the objective to be reached, and the nature of the host-pathogen
relationship [3]. For these complex cases, the definition developed by Diekmann and
Heesterbeek [11, 12], defined as Basic Reproduction Ratio, has been used to study the
threshold criteria in heterogeneous systems.
In this study, we adapted the concept of R0 to represent the phenomena of the HIV-1
infection and the dynamics of the immune system to control and eliminate it as an es-
sential tool to test a hypothesis that results in more accurate outcomes. We applied the
Next Generation Matrix Operator methodology to establish the threshold of viral infec-
tion based on immunological mechanisms, which is an important indicator of efforts to
eliminate the infection.
2. Description of the model
The model description we propose is a realization of the immune system in which
the various cell populations determine the set of equations [39, 40]. The cell popula-
tions were T , the nave and not-infected TCD4+ lymphocyte population, I, the produc-
tively infected, and L, the latently (or chronically) TCD4+ infected lymphocyte sub-
populations. The free viral load is represented by the v equation. These equations con-
sider additional cell populations that contribute to infection establishment. These cells
are Mp, active not-infected macrophages; Mpi, active infected macrophages; iDC, im-
mature not-infected dendritic cells and mDC the infected and mature dendritic cells.
The CTL compartment of the model represents the cytotoxic action of TCD8+ lym-
phocytes. The effectors and the memory cytotoxic lymphocyte subpopulations were
considered in the CTL flux (Fig. 1). All kinetic parameters representing the global flux
are shown in Table 1.
The macrophage population is presented by (1),
dMp
dt
= sm + l1Mp − δ fMp − β1 v
n
vn + Kv
Mp (1)
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Once the HIV virus penetrates the tissue barriers, macrophage sentinels find it and sig-
nal other immune cells. In (1), macrophages are recruited by a sm rate and activated
according to the immune response level by l1 rate. δ f is the natural death rate. Once
active macrophages contact viral particles, the particles are absorbed, and these absorp-
tion processes are represented by a saturation term (Holling II type), with a maximum
rate parameter β1 to lead to production of antigens. The exponent n is a Hill coeffi-
cient and represents the possible cooperation among the HIV-1 molecular interactions
with active macrophages. The viral particle ingestion initiates the active and infected
macrophage population according to (2),
dMpi
dt
= β1
vn
vn + Kv
Mp − (δ f + α′)Mpi − βmfMpi T − k1MpiCTL . (2)
These population dynamics show that infected macrophages do not suffer from the
HIV-1 cytolytic effects as strongly as Tcells, and they can remain in the viral reservoir
for a long period. According to Perno et al. [13] and Aquaro et al. [14], virions may
occur in macrophages with genetic sequences and different alternative splicing of those
found in infected lymphocyte TCD4+ cells, showing a lesser genetic variance. These
infected macrophages are given an additional death rate, α′, that reflects possible HIV
biochemical effects in cytosol, leading to an apoptosis state. The infected macrophages
carry trapped viral particles to TCD4+ lymphocyte activation in the so-called ”infec-
tious synapse” process. These phenomena were quantified in the third term of (2),
according to the Mass Action Law. βmf is the parameter encapsulating the contact
and complex formation rate. The last term in (2) shows the cell-cell encounter rate
displayed by the immune response. This immune action, related to the destruction of
these infectious cells by cytotoxic Tcell lymphocytes (CTL), is proportional to the rate
k1.
During the HIV particle bypassing the tissue barriers, the recognizing process is acti-
vated, and the adaptive immune response initiates the presenting process by the den-
dritic cells. The sid parameter shows the cell influx into a specific tissue, and the
increase of the active cell concentration (by adaptive immune response) is shown by
the second term in (3), with the l2 parameter representing the activation rate.
diDC
dt
= sid + l2 iDC − δidiDC − K1 vv + κv iDC . (3)
in which dendritic cells die a natural death at the rate δid. It was demonstrated that the
relationship between the number of viral particles and mono-covalent connections to
DC-membrane receptors follow a saturation process over time, according to Vanham
et al. [15] and Hlavacek et al. [16, 17]. The simpler mathematical expression used to
represent these phenomena resembles the enzymatic rate by Michaelis-Menten. The
process in which the virus has been holding onto the receptor is encapsulated in the
third term of (3), where K1 is the maximum rate of the connected virus to cellular
membrane receptors, κv is the viral particle half-maximum concentration of dendritic
cells. This formulation was chosen instead of Mass Action Law to exhibit the biochem-
ical mechanisms described by Stebbing and Bower [18] and Wu and Kewalramari [19].
During this process, these cells mature (mDC) and process antigens into MHC class II
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complex, activating TCD4+ lymphocytes (4). Therefore, the mDC expression is
dmDC
dt
= K1
v
v + κv
iDC − δdc mDC − βdcmDC T − k2 mDCCTL . (4)
The number of contacts between these mature dendritic cells (with fragments or entire
virus trapped) and nave TCD4+ lymphocytes is proportional to these two populations
and has the probability βdc [20]. These cells die at a rate δdc due to the death cell ac-
tivation induced process [21] and CTL lymphocyte cytotoxic action, at a rate k2. The
infected dendritic cell population directly migrates to the interior of the lymphoid or-
gans to meet nave TCD4+ lymphocytes, activating and infecting it. The efficiency of
infection in these lymphocytes is intimately associated with the viral integrity, an ef-
fective transfection process and adequate trapping in viral and Tcell binding [22–24].
The TCD4+ lymphocyte population has a nave cell s4 influx. These lymphocytes are
activated after contact with HIV-infected macrophages or dendritic cells, which occurs
during the antigen-presenting process and is increased by cloning expansion (5). In
active HIV-infected macrophages, this viral transport can occur in lymph organs or at
inflammation sites [25]. The βdc and βmf parameters are contact rates that quantify the
intensity of the adaptive immune response and the T-cell activation level by antigen
processing [26]. Additionally, ξ and φ parameters define, respectively, the infectious
contact parameters of macrophages and dendritic cells in the antigen-presenting pro-
cess. This antigen presentation was modeled by Queuing Theory, considering that the
arriving process is close to a Poisson distribution’s mean 1/c [27]. The c parameter
shows the exponential decay life expectancy of free virus in blood. The survivor virus
from immunological attack reaches the nave or active CD4 molecules with probability
[1 − exp(−ct)]/c, with the parameter a representing the probability of the encounters
to be infectious. Thus, the mathematical expression Ψ(a, c; t) = a[1 − exp(−ct)]/c rep-
resents the efficiency of infectious contact between dendritic cells or macrophages, in
the antigen presentation, and TCD4+ and CTL lymphocyte activation. The dynamics
of nave TCD4+ lymphocytes follow the expression,
dT
dt
= s4 +
(
βmfMpi + βdc mDC
)
T − Ψ(a, c; t) (ξMpi + φmDC)T − δT . (5)
This mathematical formulation of an infectious encounter is very similar to the model
used by McDonald in vector-host diseases [10, 27].
After some nave lymphocytes are activated and infected, a proportion f becomes pro-
ductively infected TCD4+ lymphocytes and a proportion (1 − f ) becomes chronically
infected. It is assumed that this last T-cell group is activated at 0.0005 cell (µl.day)−1
[28], depending on the need to struggle with opportunistic infections, and it produces
a virus in this process, as shown by (6 and 7),
dI
dt
= f Ψ(a, c; t) (ξMpi(t − τ) + φmDC(t − τ))T (t − τ) e−(δ+α∗)τ
−(δ + α∗)I + 0.0005 L − k3I CTL ,
(6)
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and,
dL
dt
= (1 − f ) Ψ(a, c; t) (ξMpi(t − τlat) + φmDC(t − τlat))T (t − τlat) e−(δ+α∗lat)τlat
−(δ + α∗lat)L − 0, 0005L .
(7)
Within these equations, τ and τlat parameters represent the period that HIV needs to
complete its life cycle in a host cell. The infected T-cells die due to the HIV cytolytic
action or the CTLs immune response intensity. This occurrence is described by α∗ and
α∗lat parameters and the cell life expectancy by (δ+α
∗) and (δ+α∗lat), which are the death
rate parameters associated with productive and chronic cell populations, respectively.
The CTL cells play an important role in the immune process, signaling infected cells
and destroying them by apoptosis mechanisms. Equation (8) shows the dynamics of
the CTL lymphocyte population on the immune system to control the spread of infec-
tion. The first term, s8, represents the cell influx, and δctl represents the natural death
rate. ξ′ and φ′ are parameters related to the activation of induced cell death of CTL
by macrophages and dendritic cells, respectively. Each population cited previously
contributes to immune response level through the rates kctli (i=1,2,3), cooperating to
increase the active effectors in the CTL population.
dCTL
dt
= s8 − δctlCTL − (ξ′Mpi + φ′mDC)CTL
+
(
kctl1 Mpi + k
ctl
2 mDC + k
ctl
3 I
)
CTL
(8)
Viral balance (9) shows the formation of free HIV-1 virus particles in the blood. The
dynamics follow the expression,
dv
dt
= Q1(δ + α∗)I + Q2(δ + α∗lat)L + Q3Mpi − K2iDC v − σ
vn
vn + κv
Mp − c v . (9)
where the two first terms represent the contributions from productively and chronically
infected lymphocyte subpopulations, after cell death by HIV-1 cytolytic effects. The
third term indicates the infected macrophage population effect on basal viral load. Pa-
rameters Q1, Q2 and Q3 are the rates of participation of each infected cell population in
HIV dissemination and viral pathogenesis. The other terms described as the free viral
particles are withdrawn from the blood by dendritic cells (at rate K2) and the numbers
of HIV-1 virions that are encountered (and are captured) by active macrophages (at
rate σ). c is the viral clearance. These parameters evaluate the efficacy of the immuno-
logical actions. All kinetic parameters were based on immunological and biochemical
mechanisms of the immune response to the HIV infection process and were gathered
from cited literature. The values are shown in Table 1.
2.1. Threshold calculation
The necessity of considering other cellular reservoirs in addition to the TCD4+
lymphocytes (such as macrophages and dendritic cells) is very important for HIV
spread containment and its complete control into the patients body, as well as the ex-
istence of a remarkable high efficiency of HIV vaccines. The model (1-9) represent,
from a mathematical point of view, the immunological aspects of HIV infection, the
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Table 1: Parameter values and biochemical meanings for parameter set from Equations 1-9
Parameter Value (unit) Biochemical meaning References
sm 16.3 cell(µl.day)−1 Active macrophage influx rate [36]
l1 0.002 cell(µl)−1 Activated macrophage growth rate [36]
β1 1.10 Infected macrophage with viral particles [38, 39]
n 0.55 Hill coefficient Adopted
Kv 100 virions(ml)−1 Saturation coefficient Adopted
δ f 0.0285 (day)−1 Activated macrophage natural death rate [36]
βmf 4.50×10−04(day)−1 Macrophage and CD4+ lymphocyte contact activation rate [15]
α′ 0.02 (day)−1 Infected macrophage death rate due to HIV virus [38]
sid 37.6 cell(µl.day)−1 Immature dendritic cell influx rate [24, 40]
l2 0.085 cell(µl)−1 Dendritic cell growth rate [33]
K1 145 Immature dendritic cell with viral particles [33]
κv 4.5 Complex Dendritic cell HIV saturation constant Adopted
δid 0.005 (day)−1 Immature dendritic cell natural death rate [15]
βdc 4.17×10−03(day)−1 Dendritic cell and CD4+ lymphocyte contact activation rate [32]
δdc 0.025 (day)−1 Infected mature dendritic cell death rate [38]
s4 0.025 cell(µl.day)−1 Lymphocyte CD4+ influx rate [24, 40]
a [0..1] Effective contact fraction among activated and infected cells
ξ 0.0028(day)−1 Infected macrophage and TCD4+ contact rate Estimated
φ 8.62×10−05(day)−1 Infected dendritic cell and TCD4+ contact rate Estimated
δ 0.015 (day)−1 Activated lymphocyte CD4+ natural death rate [32]
f [0..1] Productively infected lymphocyte CD4+ fraction
τ 0.13 day Lymphocyte CD4+ intracellular viral production delay [1]
α∗ 0.332 (day)−1 Productively infected lymphocyte CD4+ additional death rate [1, 40]
τlat 20 day Viral production in latent lymphocyte CD4+ delay Adopted
α∗lat 0.132 (day)
−1 Latent lymphocyte CD4+ additional death rate [32]
s8 0.0023 cell(µl.day)−1 CD8+ lymphocyte influx rate [40]
δctl 0.136 (day)−1 CD8+ lymphocyte natural death rate [32]
k1 1.50×10−03(day)−1 Infected macrophage and effector CTL contact rate [37]
k2 2.00×10−04(day)−1 Dendritic cell-HIV complex and effector CTL contact rate [37]
k3 2.50×10−04(day)−1 Infected CD4+ lymphocyte and effector CTL contact rate [37]
Q1 750 virions(cell)−1 Viral particle number per activated infected CD4+ lymphocyte [32]
Q2 80 virions(cell)−1 Viral particle number per latently infected CD4+ lymphocyte [32]
Q3 250 virions(cell)−1 Viral particle number per infected macrophage [3]
K2 0.15 ml(cell)−1 Absorption rate of HIV particles by immature dendritic cells [15]
σ 0.82 ml(cell)−1 Absorption rate of HIV particles by activated macrophages [15]
ξ′ 4.80×10−04 (day)−1 Infected macrophage induced CTL death rate Estimated
φ′ 2.10×10−02 (day)−1 Mature dendritic cell induced CTL death rate Estimated
kctl1 1.50×10−03 cell(µl.day)−1 CTL growth rate related to infected macrophage [40]
kctl2 1.50×10−04 cell(µl.day)−1 CTL growth rate related to mature dendritic cells [40]
kctl3 6.1755×10−03 cell(µl.day)−1 CTL growth rate related to infected CD4+ lymphocyte [40]
c 2.3 (day)−1 Viral clearance rate [3]
growth and death rates, the number of contagious contacts (as the force of viral spread)
and the ”control” exerted by CTL populations on viral dissemination. This approach
is very interesting to understand which factors in HIV infection mechanisms are im-
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portant to initiate cell invasion, proliferation and dissemination, and to deplete TCD4+
populations, which cause impairment of the human immune system.
Equations (1-9) were conducted using Berkeley Madonna software 8.0.1, and simula-
tion runs were performed with fourth order Runge-Kutta integration algorithm. The
main objective was reaching the exact prediction of the HIV infection and disease evo-
lution in an untreated patient.
3. Results and Discussion
The TCD4+ lymphocyte dynamics (Fig. 2) are similar to the classic HIV values
found in the literature, and differences that appear could be due to the delays in the
model. If we consider the biochemical events relative to the viral life cycle and the
cell host half-life, this ”time dilation” between the arrival and the completion of com-
plete virions could be a type of immune system adaptation process to HIV-1. In the
early phase of the disease (0 to 60 days) (Fig. 2), approximately 6.0 % of TCD4+
lymphocytes were infected. In the asymptomatic phase, this content was almost 8.4 %.
In chronically infected TCD4+ lymphocytes the content was 2.0 % of the total lym-
phocyte population in the early phase and 0.15 % in asymptomatic phase. However,
if we consider the delayed input, the chronically infected TCD4+ lymphocytes play a
specific (and unclear) role and act as a possible reservoir to HIV pathogenesis. The
formation of the productively infected TCD4+ cells (Fig. 3) follows the profiles cited
in specific HIV literature. In this figure, the value reaches 55 cells µl−1 (in the early
phase) and 65 cells µl−1 during the asymptomatic phase and constant cytotoxic lym-
phocyte pressure. In evaluating the beginning of infection more carefully, the peak of
infected cells reaches 100 cells µl−1 in a time interval that is dependent or independent
of delay. The infected lymphocytes show a death rate of approximately 0.0067 day−1
due to CTL action. The relationship between the infected TCD4+ and the CTL content
is approximately 18 %, similar to [34].
3.1. Macrophage cells
When active macrophages meet viral particles, there is an increase in these cells
at inflammation sites during early infection stages, and a small proportion suffer from
infection. The mathematical simulations showed that 34 % of total active macrophages
become infected (almost two-fold the value found in [29] during the installation phase
of HIV pathogenesis), and this level reaches 43 % during the asymptomatic phase. The
kinetics of macrophage proliferation show a pseudo-steady state in infected macrophage
dynamics (Fig. 4), reaching an average content of 18 cells µl−1. Considering that nearly
one-third of active macrophages become infected, its importance as a viral prolifera-
tion reservoir and infection maintenance is significant.
The dynamical equilibrium, as described in (8), is modified by CTL lymphocyte pop-
ulation interference. The parameter k1, representing the cytotoxic lymphocyte actions
in the infected macrophage cell control, transfers a large sensibility to system equilib-
rium, but this control is not as pronounced in dendritic cells. All these characteristics
reflect the control of infection dynamics.
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3.2. Dendritic cells
The dendritic cells show a similar profile to the macrophage population. During the
first 60 days (early infection phase), approximately 95 % of mature dendritic cells have
some viral particles trapped on its receptors. After an initial period, we can imagine
that all dendritic cells derived from recognized HIV virions are infected. An equilib-
rium baseline is established (corresponding to the asymptomatic phase) at an average
concentration of 15 cells µl−1. In the last infection phase (Fig. 5), there is an exponen-
tial increase of infected cells and viral proliferation rate [30]. In analyzing the kinetics
parameter values and the simulation outcomes, the amount of virions absorbed per cell
is 80 virions.cell−1. This value is in agreement with the range of 100 to 180 particles
per cell shown by Moris et al. [31] and Haase et al. [32]. The contact rate range be-
tween dendritic cells trapping virus and TCD4+ lymphocytes is 0.088 [15] and 0.0109
[31]. The value of saturation constant κv was obtained from simulation outcomes.
3.3. CTL lymphocytes
The mathematical simulations show the three stages of viral infection (Fig. 4): (a)
the initial equilibrium perturbation as the viral cycle and infection is established; (b)
the asymptomatic or chronic phase, in which a pseudo-steady state occurs in all cellular
compartments and the virus spreads posteriorly, and (c) the final phase, in which the
viral proliferation leads to depletion of the immune system. The CTL population is
not sufficient to eradicate the HIV presence or the infection propagation because of
either viral escape mechanisms or signaling cytokine depletion in the immunological
response.
According to Rouzine et al. [33], there could be two possible mechanisms to control the
HIV spread, and both relate to the viral load level. If the viral load is lower, the effort
of CTL lymphocytes is TCD4+ active concentration dependent. A higher viral load
is TCD4-independent but antigen-presenting dependent. This control mechanism can
be verified in (8) and results from a mathematical simulation, in which the TCD4/CTL
ratio reaches values between 2.67 and 1.85. The viral escape phenomena, related to the
inefficiency of CTL control, can be observed in Figs. 1 to 5.
3.4. Infection level
This study adapts the ”force of infection” and ”basic reproduction number” epi-
demiological methodologies, which are well established in epidemiological studies, as
parameters of disease propagation in a susceptible population. In our study, the param-
eters represent the intensity of the antigen-presenting process, produced by infected
macrophages and dendritic cells at infectious synapses, to nave TCD4+ lymphocytes
in the adaptive immune response. After the pathogen-host complexes are formed, HIV
is transferred to TCD4+ lymphocytes, where its genetic material is injected into host
DNA, destroying it and infecting other susceptible cells. The progression of the dis-
ease is quantified by an index called Basic Reproduction Number, which corresponds
to the average number of secondary cases that a unique infected case will cause in a
susceptible population without treatment or any control of the infectious process [12].
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3.5. Basic reproductive number calculation
After HIV penetrates the tissue barrier, it starts a cascade of cellular and biochem-
ical mechanisms represented by the model (1-9). The efficiency of the humoral and
adaptive response is represented in the matrix Σ (A.1, Appendix A), which shows
the probability of virus elimination (the first to fifth row) and the life expectancy of
HIV in human blood (last vector in the form of the clearance rate c). The matrix Λ
(A.2, Appendix A) represents the death rates of infected cell populations, such as in-
fected macrophages or mature dendritic cells and productively infected TCD4 lympho-
cytes. The last two vectors are zero because they are representatives of populations of
CTL lymphocytes and viral load. Conceptually, the spectral radius ρ(K) is the largest
absolute value of an eigenvalue of K (K= -Σ(s)Λ−1 where ρ(K)) = sup |λ|; λ ∈ σ(K))
and is associated with R0, according to (10). Mathematically, the spectral radius related
to some positive matrix considers the expected numbers of offspring that an average in-
dividual would produce during its lifetime if the population lingers at low density. Each
(i, j) entry of the Next Generation Matrix K (A.4, Appendix A) is an expected number
of secondary infections produced in compartment i by a case initially in j.
This concept is related to the balance between the production of new infections by
the group of infected or uninfected macrophages and dendritic cells on TCD4+ lym-
phocytes. It is also related to the control of viral proliferation (with their removal)
generated by HIV-specific CTL response. Herein, the constant antigen presentations
by HIV-infected macrophages impact new generations of viral infections and remain
important reservoirs to the continuity of HIV proliferation and T-cell depletion.
By applying the next generation matrix methodology on model (1-9), the outcome is
R0(τ) =
f ξ
δ + α∗ − 0.0005Mpi(τ) +
(1 − f ) φ
δ + α∗lat + 0.0005
mDC(τ). (10)
Equation (10) shows that a possible target to the drug’s action is focused on the τ term.
The sensitivity is seen in 11, showing that the depletion profile of TCD4+ lympho-
cytes depends on the viral infection in macrophages and dendritic cells and the level
of immunization. Additionally, in analyzing the destruction of all infected cells, such
as HIV-infected macrophages, the variation of R0 has a linear dependence on the death
rate of these cells. Thus, although the target cells used by drug therapy are TCD4+
lymphocytes, the presence of dendritic cells and macrophages working like antigen-
presenting cells still causes new infections, which maintain low levels of HIV virus.
However, any inflammation process could trigger new HIV infection cases in lympho-
cytes resulting in viral load elevation and dissemination of the virus.
A sensitivity analysis in (10) of each parameter is shown by (and Appendix B),
∂R0
∂(δ + α∗)
= − f ξMpi(τ)
(δ + α∗)2
(11a)
∂R0
∂(δ + α∗lat)
= − f ξMpi(τ)
(δ + α∗lat)2
(11b)
∂R0
∂ξ
= − f ξMpi(τ)
(δ + α∗) − 0.0005 (11c)
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∂R0
∂φ
= − f ξmDC(τ)
(δ + α∗lat) + 0.0005
(11d)
∂R0
∂τ
=
dτ
dt
[
f
ξ
δ + α∗
∂Mpi(τ)
∂τ
+ (1 − f ) φ
δ + α∗lat
∂mDC(τ)
∂ τ
]
(11e)
Equations (11a) to (11e) show the relationship between the R0 index and the lym-
phocyte TCD4+ life expectancy, which notes that higher productively or chronically
infected lymphocyte death rates are associated with lower rates of infection during the
adaptive immune response. During the acute (or early) stage, cellular lyses induced by
HIV occur and infected cells die by CTL action (11a and 11b). Thus, if the cell-host
dies, virus survivors are killed by the immune system. However, this dynamic equilib-
rium does not lower viral proliferation, and HIV-1 continues to infect and proliferate
(under mutant particles form) escaping the immune system and infecting new target-
cells. Thus, the vicious cycle restarts.
After the acute phase, the viral load is defined by the HIV replication rate and its
clearance. Blips of intense viral replication are found during this period and are most
likely caused by the inflammation process or opportunistic infections triggered by
macrophages (or dendritic cells) and lymphocyte cell interaction. Hence, if HIV-
infected macrophages (or dendritic cells) interact with nave TCD4+ and infect them,
starting a new viral dissemination wave, the viral proliferation triggers other infected
TCD4+ lymphocytes. This process is presented in (11c) and (11d). Specific studies
[9, 14] cite that the viral population within the infected macrophages has a different
mutant profile compared to that found in the infected lymphocyte subpopulation, prob-
ably due to different selective pressures to which HIV-1 is exposed. This information
could explain the rapid dominance of wild-type virus after therapy cessation (Equations
10 and 11).
4. Conclusion
Equation 11e relates the impact of viral dissemination (e.g., the infection level) and
the HIV replication cycle on infected macrophages and dendritic cells. It concludes
that the interaction between the HIV virus and these host cells seems to have a pro-
found influence on the exhaustion rate of the immune system.
The relations f Ψ(a, c; t)ξ and f Ψ(a, c; t)φ show the efficiency of each contact between
HIV-infected macrophages and dendritic cells, respectively, to lymphocyte T-cells in
the antigen-presenting process. As the aξ and aφ terms represent the content of viral
particles that infect the host cell and f is the fraction of lymphocytes that are pro-
ductively infected (the expression in parentheses represents the virus that survives the
immune system attack), pre-exposure prophylaxis treatment therapies with fusion- or
ligand-inhibitor drugs, for example, decrease the contact terms aξ and aφ. This process
could be a barrier of viral entrance into the intracellular host environment. Infectious
contacts caused by HIV-infected macrophages and dendritic cells lead to new infec-
tions in nave TCD4+ lymphocyte cells, influencing new immune responses to avoid vi-
ral proliferation, which could result in immune reconstitution inflammatory syndrome.
The R0 equation shows the mechanism of immune response that may relate to the tar-
gets of new drugs or new forms of pre-exposure prophylaxis treatment. The impact of
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new approaches to treatment can lead to the partial eradication of the disease and the
formation of strains resistant to antiviral drugs by acting on cell tropism used by the
viral subtypes present to infect. The model shows that populations of macrophages and
dendritic cells constitute possible therapeutic targets to combat HIV/AIDS and targets
for vaccination schemes.
Appendix A. The Next Generation Matrix Development
HIV-1 penetration through the tissue barrier starts a cascade of cellular and bio-
chemical mechanisms attributable to this pathogen. The matrix (M2 + D) (A.1) is
composed of death rates of infected cell populations, such as infected macrophages,
mature dendritic cells carrying viruses and productively infected lymphocytes TCD4
cells. The immune response depends on the humoral and adaptive response efficiency
response, represented by matrix (M1 + Σ) (A.2), which includes the probability of virus
elimination (the first to fifth row) and the life expectancy of HIV in human blood (last
vector in the form of the clearance rate c). The components of the last two vectors are
zero because they are related to populations of CTL lymphocytes and viral load.
Mathematically, the spectral radius from a positive matrix is the expected number of
offspring that an average individual would produce during its lifetime if the population
decreases at low density. Each i or j entry of the matrix K (A.4) is an expected number
of secondary infections produced in compartment i by a case initially in compartment
j. Starting from the model described by equations A to B, let x(t) be the vector of popu-
lations and, assuming the TCD4+ lymphocyte population is large and the total number
of cells infected at early stages of HIV infection is small, it is possible to assume that,
x′(t) = T (s).x(t) − V.x(t)
The components of (M2 + D) and (M1 + Σ) matrices represent all rates that contribute
to new infections at stage j caused by contacts with an individual patient in stage i and
all death rates that contribute to decreasing the disease proliferation. D is a positive di-
agonal matrix of removal (or death) rates, and Σ represents all the removal rates caused
by CTL lymphocyte control. When these two matrices are added, the matrix outcome
is M2 + D + M1 + Σ = V (-V is a Metzler matrix if V= mi j ∈ Rnxn all off-diagonal
entries have non-negative values) (i.e., mi j > 0, i , j).
T(s) is a non-negative transmission matrix, occurring by indirect form (by vector, in-
termediary host, contaminated food or environmental problem), horizontal direct form
among individuals, vertical transmission (as mother-to-child infection type) and diag-
onal transmission. Thus, using an operator based in M-matrix theory, another matrix
K can be associated with the -V and T(s) and,
K = −T(s).V−1
Matrix K can be interpreted as a ”next-generation matrix” with respect to the infection
process. The conditions of stability of this product matrix with Metzler matrices and
threshold conditions of the system are calculated as the unique endemic equilibrium.
In the last matrix, each element shows the particular contribution of each population to
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disease proliferation and cell death. In other words, each component is a type of ”who
infects who” point-of-view. Thus,
M2 + D=
−(δ f + α′) 0 . . .
0 −δdc 0 . . .
. . . 0 −(δ + α∗) + 0.0005 0 . . .
. . . 0 −(δ + α∗lat) − 0.0005 0
. . . 0 0
. . . 0

(A.1)
and
M1 + Σ= 
0 . . . . . . β1Mp
0 . . . . . . K1iDC
. . . 0 . . .
. . . 0 . . .
kctl1 − ξ′ kctl2 − φ′ kctl3 0 −δctl 0
. . . 0 −c

(A.2)
The elements of T(s) matrix are related to any entry that has any contribution to in-
crease or elevate the cellular populations, as shown in (A.3),
T(s)=
−βmfT0 0 . . . . . . 0
0 −βdcT0 0 . . . . . . 0
ΞT (τ) ΦT (τ) ΞMpi(τ) ΦmDC(τ) 0 . . .
Ξ∗T (τlat) Φ∗T (τlat) Ξ∗Mpi(τlat) Φ∗mDC(τlat) 0 . . .
0 . . . 0 −(ξ′Mpi + φ′mDC) 0
0 . . . . . . 0 −(δ.Mp + K2iDC)

(A.3)
where Ξ = f ξ, Ξ∗ = (1 − f ) ξ, Φ = fφ and Φ∗ = (1 − f ) φ.
From the model (1-9) and (M2 + D) and (M1 + Σ) matrices, we could assume that this
system has multiple discrete types of infected cell populations (macrophages, dendritic
cells and lymphocytes). The Next Generation Matrix is defined as the square matrix
K (A.4) in which the i j th elements is the expected number of secondary infections of
cell type i caused by a single infected individual (e.g., infected cell or virus particle) j,
assuming that the population from type i is entirely susceptible. Thus,
K= 
− βmf T0
δ f +α
′ 0 . . . . . . 0
βmf T0
δ f +α
′
β1Mp0
c
0 − βdcT0
δdc
K23 0 0
βdcT0
δdc
K1iDC0
c
ΞT (τ)
δ f +α′
ΦT (τ)
δdc
K33
ΦmDC(τ)
δ+α∗lat+0.0005
0 0
Ξ∗T (τlat)
δ f +α′
Φ∗T (τlat)
δdc
K43
Φ∗mDC(τ)
(δ+α∗lat)+0,0005
0 0
K51 K52 0 0
−(ξ′Mpi+φ′mDC)
δctl
0
0 . . . . . . 0 −(δ.Mp+K2iDC)c

(A.4)
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where the K23,K33, K43, K51 and K52 terms are
K23 :=
βdcT0
(δ + α∗ − 0.0005)
β1(kctl1 − ξ′)(δ f + α′)c Mp0 + K1(k
ctl
2 − φ′)
δdcc
iDC0

K33 :=
ΦT (τ)
δ + α∗ − 0.0005
β1(kctl1 − ξ′)(δ f + α′)c Mp0 + K1(k
ctl
2 − φ′)
δdcc
iDC0
 + ΞMpi(τ)
δ + α∗ − 0.0005
K43 :=
Φ∗T (τlat)
δ + α∗ − 0.0005
β1(kctl1 − ξ′)(δ f + α′)c Mp0 + K1(k
ctl
2 − φ′)
δdcc
iDC0
 + Ξ∗Mpi(τlat)
δ + α∗ − 0.0005
K51 :=
ξ′CTL0
δ f + α′
− ξ
′Mpi + φ′mDC
δctl(δ f + α′)
K52 :=
φ′CTL0
δdc
− ξ
′Mpi + φ′mDC
δctlδdc
(kctl2 − φ′). (A.5)
Appendix B. R0 equation sensitivity analysis
The sensitivity to each of the parameters described in model (1-9) is obtained by
the normalized forward sensitivity index. The generalized S p expression to a specific
parameter p is,
S p =
∑ ∂R0
∂p
p
R0
∂p
∂t
t
p
.
This mathematical relation was used to analyze cell contact, activation and death pa-
rameters. The R0 relationship with productive and chronical infected TCD4+ lympho-
cyte death rate, the antigen activation process related to encounters between macrophages
(or dendritic cells), HIV-infected and uninfected lymphocytes TCD4+, and its specific
delay τ are shown in (B.1) and (B.2),
S 1/(δ+α∗) =
t
1 + Θ(τ)
, (B.1)
S 1/(δ+α∗lat) =
t
1 + Θ−1(τ)
, (B.2)
S ξ =
ξ
1 + Θ(τ)
, (B.3)
and
S φ =
φ
1 + Θ−1(τ)
. (B.4)
where
Θ(Mpi,mDC; τ) ≡ Θ(τ) := φ
ξ
mDC(τ)
Mpi(τ)
(1 − f )
f
(δ + α∗) − 0.0005
(δ + α∗lat) + 0.0005
It is noted that, if infected lymphocyte population death rate increases by 1.0 % due
viral proliferation, the R0 value increases nearly by 2.3 % (B.1). If we consider that
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the index is related to chronically infected lymphocyte death rate, the R0 variation is
approximately lower, 0.015 % (B.2).
In the absence of antiviral treatments, the variation of 1.0 % in the parameter re-
lated to encounter rate (φ and ξ), results in a variation of nearly 0.3 % (relative to
macrophages) and 5.8× 10−5 % (relative to dendritic cells), respectively. It could in-
dicate that macrophages population stresses higher R0 than dendritic cells, conforming
showed at (B.3) and (B.4).
The R0 sensitivity is directly proportional to the complete viral life cycle over time and
the macrophage and dendritic cell infected populations, as can be seen in (B.5),
S τ =
[
∂
∂τ
R0
]
∂τ
∂t
t
R0
. (B.5)
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Figure 1: Immune system diagram showing the cell compartments involved in HIV-1 viral infection and the
relationships among them used to represent parameters in the model
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Figure 2: Simulation profiles of activated uninfected and HIV-infected macrophage populations, which show
the immune transient response outcomes from viral contact in the early phase. The activated uninfected (dark
green) and the HIV-infected macrophage cells (light green) show an early phase appears as an asymptotic
phase and rises at the end of this period (which coincides with the AIDS period)
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Figure 3: Simulation profiles of immature and mature dendritic cell populations, in which early phase ap-
pears as a rapid transient period as a result of HIV-1 contact and interaction with these cells in the antigen
presentation process. The immature (dark blue) and the mature dendritic cells (light blue) show an initial
and rapid transient phase, in which almost all dendritic cell are affected at the infection site, and it shows n
plateau (on intermediate phase) resulting in an exponential growth of mature cells level trapping HIV in the
AIDS phase.
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Figure 4: Simulation profiles of the viral load and productively HIV-infected TCD4+ lymphocyte population
dynamics during the infection time. The TCD4+ lymphocyte (in black) population shows a transient period
at an early phase during the initial immune response to HIV infection. Even as the viral load rises slowly
and the infection proliferates, the Tcell populations deplete and the immune system is impaired. Viral load
increases, spreading an exponential growth at the final phase, and rises to AIDS.
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Figure 5: Simulation profiles of infected (in gray) and chronical infected (in blue) TCD4+ lymphocyte
dynamics. The initial stage presents a transient period as a consequence of viral infectious process and
immune responses, which goes on to a stable phase referred to as the asymptomatic phase, despite the fast
growth due to intense viral proliferation and immune system depletion. The chronically infected Tcells (in
blue) show similar dynamics with lower concentration. In the AIDS phase, these two cell sets grow fast
resulting in immune system depletion.
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